| 1 | Energy | XLE | +50.0% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.6% |
| 4 | Consumer Staples | XLP | +12.0% |
| 5 | Materials | XLB | +11.5% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +3.9% |
| 8 | Financials | XLF | +2.0% |
| 9 | Utilities | XLU | -0.9% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/29/26 | $-0.37 | — | — | — | $0.5B | — | — | — |
| Q2 '26 | 8/6/26 | $-0.74 | $-0.06 | +91.9% | +96% | $0.4B | $0.4B | +9.3% | +296% |
| Q1 '26 | 5/7/26 | $-0.98 | $-0.76 | +22.4% | +46% | $0.3B | $0.3B | +1.2% | +230% |
| Q4 '25 | 2/19/26 | $-1.13 | $-1.54 | -36.3% | -17% | $0.3B | $0.3B | -0.0% | +153% |
| Q3 '25 | 10/30/25 | $-1.35 | $-1.75 | -29.6% | -38% | $0.1B | $0.1B | +23.6% | +52% |
| Q2 '25 | 8/7/25 | $-1.31 | $-1.70 | -29.8% | +12% | $0.1B | $0.1B | +3.3% | +19% |
| Q1 '25 | 5/8/25 | $-1.36 | $-1.42 | -4.4% | -34% | $0.1B | $0.1B | +0.8% | +23% |